Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer Impaired homologous recombination–mediated DNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback